All In Biotech

Drug Trial Radar · NCT05065970

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy

A Double Blind, Randomized, Placebo-Controlled, Multicenter Phase IIa, Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab in IgA Nephropathy

Last checked: Nov 20, 2026Latest source record: Apr 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

54

Actual

Start

Aug 31, 2021

Primary completion

Feb 6, 2023

Study completion May 6, 2024

Sponsor

Lead sponsor
HI-Bio, A Biogen CompanyIndustry
Sponsor type
Industry
First posted
Oct 4, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Randomized, placebo-controlled, multi-center, double-blind, proof of concept phase IIa trial and dose evaluation trial of felzartamab in IgAN

Conditions

  • Immunoglobulin A (IgA) Nephropathy

Interventions

  • FelzartamabDrug

    anti-CD38+ monoclonal antibody

  • PlaceboOther

    Placebo comparator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part 1: Relative Change From Baseline in Urine Protein to Creatinine Ratio (UPCR) in 24-hour Urine at Month 9Time frame: Baseline, Month 9

Locations

59 sites in 15 countries. Site status is shown where the registry gives one.

  • FOMAT Medical Research - FOMAT - HyperCore - PPDS

    Oxnard, California

  • Amicis Research Center, Vacaville

    Vacaville, California

  • Mayo Clinic Hospital - Methodist Campus

    Rochester, Minnesota

  • MedResearch INC

    El Paso, Texas

  • Core Research Group

    Milton, Queensland, Australia

  • Sunshine Hospital - Australia

    Saint Albans, Victoria, Australia

  • Regionaal Ziekenhuis Jan Yperman VZW

    Ieper, Belgium

  • CHU Sart Tilman Hospital

    Liège, Belgium

  • Imelda VZW

    Bonheiden, Antwerpen, Belgium

  • UZ Leuven Hospital

    Leuven, Vlaams Brabant, Belgium

  • Medical Center Hera EOOD, Montana

    Montana, Bulgaria

  • Medical Center Hipokrat- N EOOD

    Plovdiv, Bulgaria

  • University Multiprofile Hospital for Active Treatment

    Stara Zagora, Bulgaria

  • Diagnostic- Consultative Center Convex EOOD

    Sofia, Sofia-Grad, Bulgaria

  • Nemocnice AGEL Novy Jicin a.s

    Nový Jicín, Moravian-Silesian Region, Czechia

  • Eticka komise Fakultni nemocnice Olomouc

    Olomouc, Olomouc Region, Czechia

  • Fakultni nemocnice Kralovske Vinohrady Hospital

    Prague, Praha, Hlavní Mesto, Czechia

  • Vseobecna Fakultni Nemocnice V Praze

    Prague, Praha, Hlavní Mesto, Czechia

  • JSC Evex Hospitals

    Tbilisi, Georgia

  • L. Managadze National Center of Urology LTD

    Tbilisi, Georgia

  • Tbilisi State Medical University's and Ingorokva's University Clinic of High Medical Technologies

    Tbilisi, Georgia

  • Universitätsmedizin der Johannes Gutenberg-Universität Mainz

    Mainz, Germany

  • Medizinische Hochschule Hannover

    Hanover, Lower Saxony, Germany

  • Universitätsklinikum Essen

    Essen, North Rhine-Westphalia, Germany

  • National Hospital Organization Chibahigashi National Hospital

    Chiba, Chiba, Japan

  • Hokkaido University Hospital

    Sapporo, Hokkaidô, Japan

  • Hospital of the University of Occupational and Environmental Health, Japan

    Kitakyushu-Shi, Hukuoka, Japan

  • Kurume University Hospital

    Kurume-Shi, Hukuoka, Japan

  • Fukushima Medical University Hospital

    Fukushima, Hukusima, Japan

  • JCHO Sendai Hospital

    Sendai, Miyagi, Japan

  • Osaka University Hospital

    Suita-Shi, Ôsaka, Japan

  • Japanese Red Cross Ashikaga Hospital

    Ashikaga-Shi, Tochigi, Japan

  • Juntendo University Hospital

    Bunkyō-Ku, Tokyo, Japan

  • University Malaya Medical Centre

    Pantai, Malaysia

  • St Frances Cabrini Medical Center and Cancer Institute

    Santo Tomas, Batangas, Philippines

  • Clinical Hospital Center Bezanijska Kosa

    Belgrade, Serbia

  • Clinical Hospital Centar Zvezdara

    Belgrade, Serbia

  • General Hospital Krusevac

    Kruševac, Serbia

  • University Clinical Center Nis

    Niš, Serbia

  • Clinical Centre of Vojvodina

    Novi Sad, Vojvodina, Serbia

Showing 40 of 59 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.